Cited by 585Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisCancer, Hypoxia, and MetabolismPulmonary Hypertension Research and Treatments

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis

Open access

Xie, Na, Tan, Zheng, Banerjee, Sami, Cui, Huachun, Ge, Jing, Liu, Rui-Ming, Bernard, Karen, Thannickal, Victor J., Liu, Gang·2015·American Journal of Respiratory and Critical Care Medicine

DOI 10.1164/rccm.201504-0780ocPMC PMC4731722

Open this paper in CoChat — free account

Abstract

Rationale: Dysregulation of cellular metabolism has been shown to participate in several pathologic processes. However, the role of metabolic reprogramming is not well appreciated in the pathogenesis of organ fibrosis. Objectives: To determine if glycolytic reprogramming participates in the pathogenesis of lung fibrosis and assess the therapeutic potential of glycolytic inhibition in treating lung fibrosis. Methods: A cell metabolism assay was performed to determine glycolytic flux and mitochondrial respiration. Lactate levels were measured to assess glycolysis in fibroblasts and lungs. Glycolytic inhibition by genetic and pharmacologic approaches was used to demonstrate the critical role of glycolysis in lung fibrosis. Measurements and Main Results: Augmentation of glycolysis is an early and sustained event during myofibroblast differentiation, which is dependent on the increased expression of critical glycolytic enzymes, in particular, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). Augmented glycolysis contributes to the stabilization of hypoxia-inducible factor 1-α, a master regulator of glycolytic enzymes implicated in organ fibrosis, by increasing cellular levels of tricarboxylic acid cycle intermediate succinate in lung myofibroblasts. Inhibition of glycolysis by the PFKFB3 inhibitor 3PO or genomic disruption of the PFKFB3 gene blunted the differentiation of lung fibroblasts into myofibroblasts, and attenuated profibrotic phenotypes in myofibroblasts isolated from the lungs of patients with idiopathic pulmonary fibrosis. Inhibition of glycolysis by 3PO demonstrates therapeutic benefit in bleomycin-induced and transforming growth factor-β1–induced lung fibrosis in mice. Conclusions: Our data support the novel concept of glycolytic reprogramming in the pathogenesis of lung fibrosis and provide proof-of-concept that targeting this pathway may be efficacious in treating fibrotic disorders, such as idiopathic pulmonary fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1164/rccm.201504-0780oc

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
The Myofibroblast
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Self-citation

Show all 57 references

Research works printed but not linked: 1

Xie, 2015, Glycolytic reprogramming is required for myofibroblast differentiation and lung fibrosis [abstract], Am J Respir Crit Care Med, 191, A4922

Sorted by citations

Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., Langhe, S. D., & Thannickal, V. J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 525
Self-citation
Targeting metabolic dysregulation for fibrosis therapy
Zhao, X. L., Kwan, J. Y. Y., Yip, K. W., Liu, P. P., & Liu, F. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 537
Aging and Lung Disease
Cho, S. J., & Stout-Delgado, H. W. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034610 · Cited by 458
Myofibroblasts and Fibrosis
Gibb, A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 467
Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis
Rho, H., Terry, A. R., Chronis, C., & Hay, N. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.013 · Cited by 436
Lung Myofibroblasts Promote Macrophage Profibrotic Activity through Lactate-induced Histone Lactylation
Cui, H., Xie, N., Banerjee, S., Ge, J., Jiang, D., Dey, T., Matthews, Q. L., Liu, R.-M., & Liu, G. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0360oc · Cited by 373
Self-citation
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 383
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function
Yu, G., Τzouvelekis, Α., Wang, R., Herazo‐Maya, J. D., Ibarra, G. H., Srivastava, A., Werneck‐de‐Castro, J. P., DeIuliis, G., Ahangari, F., Woolard, T., et al. (2017) · Nature Medicine · doi:10.1038/nm.4447 · Cited by 360
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 360
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
Chen, A.-N., Luo, Y., Yang, Y.-H., Fu, J.-T., Geng, X.-M., Shi, J.-P., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688910 · Cited by 324
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
Bueno, M., Calyeca, J., Rojas, M. M., & Mora, A. L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101509 · Cited by 280
PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis
Hu, X., Xu, Q., Wan, H., Hu, Y., Xing, S., Yang, H., Gao, Y., & He, Z. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0404-9 · Cited by 247
Succinate receptor mediates intestinal inflammation and fibrosis
Macias-Ceja, D. C., Ortiz‐Masiá, D., Salvador, P., Gisbert-Ferrándiz, L., Hernández, C., Hausmann, M., Rogler, G., Esplugues, J. V., Hinojosa, J., Alós, R., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0087-3 · Cited by 237
Mitochondrial dysfunction in fibrotic diseases
Li, X., Zhang, W. Y., Cao, Q., Wang, Z., Zhao, M., Xu, L., & Zhuang, Q. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00316-9 · Cited by 229
Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis
Zhao, X. L., Psarianos, P., Ghoraie, L. S., Yip, K. W., Goldstein, D. P., Gilbert, R. W., Witterick, I., Pang, H. Y. M., Hussain, A., Lee, J. H., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0008-5 · Cited by 236
A PRDM16-Driven Metabolic Signal from Adipocytes Regulates Precursor Cell Fate
Wang, W., Ishibashi, J., Trefely, S., Shao, M., Cowan, A. J., Sakers, A. P., Lim, H., O’Connor, S., Doan, M. T., Cohen, P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.005 · Cited by 223
Inhibition of glycolysis alleviates lipopolysaccharide‐induced acute lung injury in a mouse model
Zhong, W., Yang, H., Guan, X., Xiong, J., Sun, C., Zhang, C., Luo, X., Zhang, Y., Zhang, J., Duan, J., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27261 · Cited by 216
PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension
Cao, Y., Zhang, X., Wang, L., Yang, Q., Ma, Q., Xu, J., Wang, J., Kovács, L., Ayon, R. J., Liu, Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821401116 · Cited by 213
Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking
Xu, H., Ling, M., Xue, J., Dai, X., Sun, Q., Chen, C., Liu, Y., Zhou, L., Liu, J., Luo, F., et al. (2018) · Theranostics · doi:10.7150/thno.27876 · Cited by 208
The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation
Wang, Y., Li, H., Jiang, S., Fu, D., Lu, X., Lu, M., Li, Y., Luo, D., Wu, K., Xu, Y., et al. (2024) · Kidney International · doi:10.1016/j.kint.2024.04.016 · Cited by 207
Glutamine Metabolism Is Required for Collagen Protein Synthesis in Lung Fibroblasts
Hamanaka, R. B., O’Leary, E. M., Witt, L. J., Tian, Y., Gökalp, G. A., Meliton, A. Y., Dulin, N. O., & Mutlu, G. M. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0008oc · Cited by 195
Mitochondrial quality control in pulmonary fibrosis
Larson‐Casey, J. L., He, C., & Carter, A. B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101426 · Cited by 192
Involvement of the Warburg effect in non‐tumor diseases processes
Chen, Z., Liu, M., Li, L., & Chen, L. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25998 · Cited by 185
Glutaminolysis is required for transforming growth factor-β1–induced myofibroblast differentiation and activation
Bernard, K. F., Logsdon, N. J., Benavides, G. A., Sanders, Y. Y., Zhang, J., Darley-Usmar, V. M., & Thannickal, V. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000444 · Cited by 181
Self-citation
Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer
Τzouvelekis, Α., Gomatou, G., Bouros, E., Trigidou, R., Tzilas, V., & Bouros, D. E. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.04.114 · Cited by 182
mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β 1 –induced collagen biosynthesis
Selvarajah, B., Azuelos, I., Platé, M., Guillotin, D., Forty, E. J., Contento, G., Woodcock, H. V., Redding, M., Taylor, A. R., Brunori, G., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav3048 · Cited by 176
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis
Ryu, C., Sun, H., Gulati, M., Herazo-Maya, J. D., Chen, Y., Osafo-Addo, A., Brandsdorfer, C., Winkler, J., Blaul, C., Faunce, J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2480oc · Cited by 171
Lung cancer in patients with idiopathic pulmonary fibrosis
Karampitsakos, Τ., Tzilas, V., Tringidou, R., Steiropoulos, P., Aidinis, V., Papiris, S. A., Bouros, D. E., & Τzouvelekis, Α. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.03.016 · Cited by 173
Transforming Growth Factor (TGF)-β Promotes de Novo Serine Synthesis for Collagen Production
Nigdelioglu, R., Hamanaka, R. B., Meliton, A. Y., O'Leary, E., Witt, L. J., Cho, T., Sun, K., Bonham, C., Wu, D., Woods, P. S., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756247 · Cited by 169
Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis
Goodwin, J., Choi, H., Hsieh, M.-H., Neugent, M. L., Ahn, J., Hayenga, H. N., Singh, P. K., Shackelford, D. B., Lee, I., Shulaev, V., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0186oc · Cited by 174
Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate–mediated mTOR Activation and Proline Hydroxylation
Ge, J., Cui, H., Xie, N., Banerjee, S., Guo, S., Dubey, S., Barnes, S., & Liu, G. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0238oc · Cited by 166
Self-citation
Mitochondrial calcium exchange links metabolism with the epigenome to control cellular differentiation
Lombardi, A. A., Gibb, A., Arif, E., Kolmetzky, D. W., Tomar, D., Luongo, T. S., Jadiya, P., Murray, E. K., Lorkiewicz, P., Hajnóczky, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12103-x · Cited by 167
Epithelial–mesenchymal transition in tissue repair and degeneration
Youssef, K. K., & Nieto, M. A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00733-z · Cited by 165
Cellular Metabolism in Lung Health and Disease
Liu, G., & Summer, R. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114640 · Cited by 157
Self-citation
Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis
Wang, Y., Lu, M., Xiong, L., Fan, J., Zhou, Y., Li, H., Peng, X., Zhong, Z., Wang, Y., Huang, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2218-5 · Cited by 161
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
Zank, D. C., Bueno, M., Mora, A. L., & Rojas, M. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00010 · Cited by 152
Alpha-enolase regulates the malignant phenotype of pulmonary artery smooth muscle cells via the AMPK-Akt pathway
Dai, J., Zhou, Q., Chen, J., Rexius‐Hall, M. L., Rehman, J., & Zhou, G. (2018) · Nature Communications · doi:10.1038/s41467-018-06376-x · Cited by 149
Augmentation of scleral glycolysis promotes myopia through histone lactylation
Lin, X., Lei, Y., Pan, M., Hu, C., Xie, B., Wu, W., Su, J., Li, Y., Tan, Y., Wei, X., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.023 · Cited by 148
Glucose Transporter 1–Dependent Glycolysis Is Increased during Aging-Related Lung Fibrosis, and Phloretin Inhibits Lung Fibrosis
Cho, S. J., Moon, J.-S., Lee, C.-M., Choi, A. M. K., & Stout-Delgado, H. W. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0225oc · Cited by 133
Fructose 2,6-Bisphosphate in Cancer Cell Metabolism
Bartrons, R., Simon‐Molas, H., Rodríguez‐García, A., Castaño, E., Navarro‐Sabaté, À., Manzano, À., & Martinez‐Outschoorn, U. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00331 · Cited by 136
Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-β
Yin, X., Choudhury, M., Kang, J. H., Schaefbauer, K. J., Jung, M.-Y., Andrianifahanana, M., Hernandez, D. M., & Leof, E. B. (2019) · Science Signaling · doi:10.1126/scisignal.aax4067 · Cited by 133
Dysregulation of metabolic pathways in pulmonary fibrosis
Rajesh, R., Atallah, R., & Bärnthaler, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108436 · Cited by 132
Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis
Parimon, T., Hohmann, M. S., & Yao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126214 · Cited by 123
Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells
Wei, Q., Su, J., Dong, G., Zhang, M., Huo, Y., & Dong, Z. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00422.2018 · Cited by 122
The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment
Zhang, Y., Peng, Q., Zheng, J., Yang, Y., Zhang, X., Ma, A., Qin, Y., Qin, Z., & Xiang, Z. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.006 · Cited by 133
PFKFB3-Driven Macrophage Glycolytic Metabolism Is a Crucial Component of Innate Antiviral Defense
Jiang, H., Shi, H., Sun, M., Wang, Y., Meng, Q., Guo, P., Cao, Y., Chen, J., Gao, X., Li, E., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600474 · Cited by 117
Advances and challenges in kidney fibrosis therapeutics
Abbad, L., Estève, E., & Chatziantoniou, C. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00934-5 · Cited by 133
PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses
Tsubouchi, K., Araya, J., & Kuwano, K. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0077-6 · Cited by 117
Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria
Veith, C., Boots, A. W., Idris, M., van Schooten, F., & van der Vliet, A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7742 · Cited by 114
Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis
Zhao, H., Dennery, P. A., & Yao, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00521.2017 · Cited by 116
The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury
Li, Z., Lu, S., & Li, X. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03892-w · Cited by 115
Mitochondrial Dysfunction in Pulmonary Fibrosis
Rangarajan, S., Bernard, K. F., & Thannickal, V. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201705-370aw · Cited by 107
Self-citation
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
Lin, Y., & Xu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593283 · Cited by 109
Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids
Roque, W., & Romero, F. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00586.2020 · Cited by 106
Lactate and lactylation in macrophage metabolic reprogramming: current progress and outstanding issues
Xu, B., Liu, Y., Li, N., & Geng, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395786 · Cited by 123
[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
Justet, A., Laurent-Bellue, A., Thabut, G., Dieudonné, A., Debray, M., Borie, R., Aubier, M., Lebtahi, R., & Crestani, B. (2017) · Respiratory Research · doi:10.1186/s12931-017-0556-3 · Cited by 106
Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus
McKay, T. B., Priyadarsini, S., & Karamichos, D. (2019) · Cells · doi:10.3390/cells8101239 · Cited by 108
Metabolic characterization and RNA profiling reveal glycolytic dependence of profibrotic phenotype of alveolar macrophages in lung fibrosis
Xie, N., Cui, H., Ge, J., Banerjee, S., Guo, S., Dubey, S., Abraham, E. H., Liu, R.-M., & Liu, G. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00235.2017 · Cited by 102
Self-citation
Regulation of glycolysis and the Warburg effect in wound healing
Vinaik, R., Barayan, D., Auger, C., Abdullahi, A., & Jeschke, M. G. (2020) · JCI Insight · doi:10.1172/jci.insight.138949 · Cited by 103
Regulation of Extracellular Matrix Production in Activated Fibroblasts: Roles of Amino Acid Metabolism in Collagen Synthesis
Kay, E. J., Koulouras, G., & Zanivan, S. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719922 · Cited by 105
TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation
O’Leary, E. M., Tian, Y., Niğdelioğlu, R., Witt, L. J., Çetin-Atalay, R., Meliton, A. Y., Woods, P. S., Kimmig, L. M., Sun, K. A., Gökalp, G. A., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0143oc · Cited by 102
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Bárcena‐Varela, M., Paish, H. L., Alvarez, L., Uriarte, I., Latasa, M. U., Santamaría, E., Recalde, M., Garate, M., Clavería-Cabello, A., Colyn, L., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320205 · Cited by 96
Fibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis
Selvarajah, B., Azuelos, I., Anastasiou, D., & Chambers, R. C. (2021) · Science Signaling · doi:10.1126/scisignal.aay1027 · Cited by 94
GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation
Cho, S. J., Moon, J., Nikahira, K., Yun, H. S., Harris, R. A., Hong, K. S., Huang, H., Choi, A. M. K., & Stout-Delgado, H. W. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213571 · Cited by 91
Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD‐L1 into extracellular vesicles
Kang, J. H., Jung, M., Choudhury, M., & Leof, E. B. (2019) · The FASEB Journal · doi:10.1096/fj.201902354r · Cited by 96
Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo
Greuter, T., Yaqoob, U., Gan, C., Jalan-Sakrikar, N., Kostallari, E., Lu, J., Gao, J., Sun, L., Liu, M., Sehrawat, T. S., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.029 · Cited by 92
The potential utility of PFKFB3 as a therapeutic target
Bartrons, R., Rodríguez‐García, A., Simon‐Molas, H., Castaño, E., Manzano, À., & Navarro‐Sabaté, À. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1498082 · Cited by 92
Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism
Hamanaka, R. B., & Mutlu, G. M. (2021) · FEBS Journal · doi:10.1111/febs.15693 · Cited by 94
Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis
Wang, Z., Chen, L., Huang, Y., Luo, M., Wang, H., Jiang, Z., Zheng, J., Yang, Z., Chen, Z., Zhang, C., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102082 · Cited by 92
Glutaminolysis Epigenetically Regulates Antiapoptotic Gene Expression in Idiopathic Pulmonary Fibrosis Fibroblasts
Bai, L., Bernard, K., Tang, X., Hu, M., Horowitz, J. C., Thannickal, V. J., & Sanders, Y. Y. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0180oc · Cited by 88
Self-citation
Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis
O’Dwyer, D. N., Ashley, S. L., & Moore, B. B. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2016 · Cited by 90
Impairment of Fatty Acid Oxidation in Alveolar Epithelial Cells Mediates Acute Lung Injury
Cui, H., Xie, N., Banerjee, S., Ge, J., Guo, S., & Liu, G. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0152oc · Cited by 88
Self-citation
The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype
Mebratu, Y. A., Soni, S., Rosas, L., Rojas, M. M., Horowitz, J. C., & Nho, R. S. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00124.2023 · Cited by 95
Recent advances in understanding idiopathic pulmonary fibrosis
Daccord, C., & Maher, T. M. (2016) · F1000Research · doi:10.12688/f1000research.8209.1 · Cited by 91
Recipient c-Kit Lineage Cells Repopulate Smooth Muscle Cells of Transplant Arteriosclerosis in Mouse Models
Ni, Z., Deng, J., Potter, C. M. F., Nowak, W. N., Gu, W., Zhang, Z., Chen, T., Chen, Q., Hu, Y., Zhou, B., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314855 · Cited by 86
The emerging role of metabolism in fibrosis
Henderson, J., & O’Reilly, S. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.05.003 · Cited by 87
Protocatechuic aldehyde protects cardiomycoytes against ischemic injury via regulation of nuclear pyruvate kinase M2
Wu, X., Liu, L., Zheng, Q., Hao, H., Ye, H., Li, P., & Yang, H. Q. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.021 · Cited by 84
Hypoxia enhances IPF mesenchymal progenitor cell fibrogenicity via the lactate/GPR81/HIF1α pathway
Yang, L., Gilbertsen, A. J., Hong, X., Benyumov, A. O., Smith, K., Herrera, J., Racila, E. V., Bitterman, P. B., & Henke, C. A. (2023) · JCI Insight · doi:10.1172/jci.insight.163820 · Cited by 85
Fibrotic pathways and fibroblast-like synoviocyte phenotypes in osteoarthritis
Damerau, A., Rosenow, E., Alkhoury, D., Buttgereit, F., & Gaber, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1385006 · Cited by 87
Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis
Hamanaka, R. B., Niğdelioğlu, R., Meliton, A. Y., Tian, Y., Witt, L. J., O’Leary, E. M., Sun, K. A., Woods, P. S., Wu, D., Ansbro, B. O., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0186oc · Cited by 81
GLP-1R activation attenuates the progression of pulmonary fibrosis via disrupting NLRP3 inflammasome/PFKFB3-driven glycolysis interaction and histone lactylation
Liu, C., Zhang, Q., Zhou, H., Jin, L., Liu, C., Yang, M., Zhao, X., Ding, W., Xie, W., & Kong, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05753-z · Cited by 87
Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis
Cui, H., Xie, N., Jiang, D., Banerjee, S., Ge, J., Sanders, Y. Y., & Liu, G. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0051oc · Cited by 76
Self-citation
Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial
Khanna, D., Padilla, C. M., Tsoi, L. C., Nagaraja, V., Khanna, P. P., Tabib, T., Kahlenberg, J. M., Young, A., Huang, S., Gudjonsson, J. E., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159566 · Cited by 76
Profibrotic up‐regulation of glucose transporter 1 by TGF‐β involves activation of MEK and mammalian target of rapamycin complex 2 pathways
Andrianifahanana, M., Hernandez, D. M., Yin, X., Kang, J. H., Jung, M., Wang, Y., Yi, E. S., Roden, A. C., LIMPER, A. H., & Leof, E. B. (2016) · The FASEB Journal · doi:10.1096/fj.201600428r · Cited by 76
TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57024-0 · Cited by 74
Self-citation
Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway
Trefely, S., Khoo, P. S., Krycer, J. R., Chaudhuri, R., Fazakerley, D. J., Parker, B. L., Sultani, G., Lee, J., Stéphan, J.-P., Torres, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658815 · Cited by 74
A high-resolution route map reveals distinct stages of chondrocyte dedifferentiation for cartilage regeneration
Chen, Y., Yu, Y., Wen, Y., Chen, J., Lin, J., Sheng, Z., Zhou, W., Sun, H., An, C., Chen, J., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00209-w · Cited by 76
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Platé, M., Guillotin, D., & Chambers, R. C. (2020) · European Respiratory Review · doi:10.1183/16000617.0269-2020 · Cited by 74
Fatty acid synthase is required for profibrotic TGF‐β signaling
Jung, M., Kang, J. H., Hernandez, D. M., Yin, X., Andrianifahanana, M., Wang, Y., González-Guerrico, A. M., LIMPER, A. H., & Leof, E. B. (2018) · The FASEB Journal · doi:10.1096/fj.201701187r · Cited by 75
Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition
Wang, Q., Liu, J., Hu, Y., Pan, T. S., Xu, Y., Yu, J., Xiong, W., Zhou, Q., & Wang, Y. (2021) · Theranostics · doi:10.7150/thno.61085 · Cited by 70
CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner
Xu, Q., Cheng, D., Li, G., Liu, Y., Li, P., Sun, W., Ma, D., & Ni, C. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57915 · Cited by 72
The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review
Zhou, B., Liu, H., Xu, F., & Jia, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01557-2 · Cited by 74
Metabolomics in chronic lung diseases
Nambiar, S., Bong, S.-H., Gummer, J. P. A., Trengove, R. D., & Moodley, Y. P. (2019) · Respirology · doi:10.1111/resp.13530 · Cited by 67
A Metabolic Reprogramming of Glycolysis and Glutamine Metabolism Is a Requisite for Renal Fibrogenesis—Why and How?
Hewitson, T. D., & Smith, E. R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.645857 · Cited by 67
The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics
Lou, Y., Zou, X., Pan, Z., Huang, Z., Zheng, S., Xiaowei, Z., Yang, X., Bao, M., Zhang, Y., Gu, J., et al. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae058 · Cited by 68
Nestin promotes pulmonary fibrosisviafacilitating recycling of TGF-β receptor I
Wang, J., Lai, X., Yao, S., Chen, H., Cai, J., Luo, Y.-L., Wang, Y., Qiu, Y., Huang, Y., Wei, X., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03721-2020 · Cited by 65
Druggability of lipid metabolism modulation against renal fibrosis
Chen, Y., Chen, X., & Zhang, S. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00660-1 · Cited by 65
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults
Marchioni, A., Tonelli, R., Andreani, A., Cappiello, G. F., Fermi, M., Trentacosti, F., Castaniere, I., Fantini, R., Tabbì, L., Andrisani, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052421 · Cited by 65

Authors: Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G.
Affiliations: University of Alabama at Birmingham (US)
Corresponding author: Liu, Gang
ORCID: Xie, Na
Tan, Zheng
Banerjee, Sami
Ge, Jing
Liu, Rui-Ming
Bernard, Karen
Thannickal, Victor J.
Liu, Gang
Venue: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Published: 2015-12
Volume: 192
Issue: 12
Pages: 1462-1474
ISSN: 1073-449X (ISSN-L)
1535-4970
DOI: 10.1164/rccm.201504-0780oc
PMC: PMC4731722
OpenAlex: W1793883704
Cited by: 582
References: 57
Citations by year: 2026: 60 · 2025: 67 · 2024: 75 · 2023: 89 · 2022: 63 · 2021: 78 · 2020: 47 · 2019: 34 · 2018: 30 · 2017: 25 · 2016: 10 · 2015: 3
FWCI: 17.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: American Journal of Respiratory and Critical Care Medicine (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL 076206, HL114470, HL-105473, R01HL105473, R01HL076206, P01HL114470)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords: glycolytic reprogramming, pulmonary fibrosis, myofibroblast differentiation, PFKFB3, 3PO, hypoxia-inducible factor-1α, succinic acid, cellular metabolism, idiopathic pulmonary fibrosis, bleomycin-induced fibrosis, TGF-β1, glycolysis inhibition, fibroblasts
MeSH terms: Animals, Cell Differentiation, Cells, Cultured, Disease Models, Animal, Glycolysis, Humans, Lung, Mice, Inbred C57BL, Mice, Idiopathic Pulmonary Fibrosis, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks